Several Indian pharmaceutical companies are ushering in the next generation of their promoter families to take over the reins ...

Hims & Hers (HIMS) doubles revenue, expands margins, and grows subscribers. Zava acquisition triples market potential, ...

The vaunted House quad-committee (quad-comm) may have one final surprise before it concludes its series of hearings on Monday ...

The Philippine National Police (PNP) will see to it that high-profile individuals evading the law are apprehended even if it ...

Vepdegestrant, an investigational estrogen receptor (ER) degrader, known as a proteolysis-targeting chimera (PROTAC ), ...

The Spinocerebellar Ataxia pipeline is advancing fast as troriluzole nears FDA nod and rivals race with gene and stem cell therapies to seize market edge. Disease modification in spinocerebellar ...

NatWest Group PLC, Pernod Ricard SA, Novo Nordisk A/S Class B, Software AG. Read 's Market Analysis on Investing.com UK.

Phase 3 results revealed Monday led shares to surge and should yield an approval application in IgA nephropathy, a ...

Americans have been clamoring for sensible prescription drug reform for years. With the stroke of his pen, President Donald Trump answered that call. His executive order aims to bring down drug ...

Tech billionaire Elon Musk denied he is taking drugs over the weekend, claiming The New York Times was “lying their a‑‑ off” in a report about his alleged drug use on the campaign trail ...

Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, United States ...

Ascletis Pharma’s acne pill has scored a phase 3 win, leading the Chinese biotech to claim the Sagimet Biosciences-sourced ...